Difference between revisions of "Israel Healthcare Ventures"
| Line 1: | Line 1: | ||
| − | [[Israel Healthcare Ventures]] (IHCV)<ref>Hebrew University of Jerusalem [ftp://ard.huji.ac.il/pub/kaye2006.pdf Isaac Kaye] Accessed 9th April 2008</ref> - [[Isaac Kaye]] is a founding member of the IHCV which was created in 2001. | + | [[Israel Healthcare Ventures]] (IHCV)<ref>Hebrew University of Jerusalem [ftp://ard.huji.ac.il/pub/kaye2006.pdf Isaac Kaye] Accessed 9th April 2008</ref> - [[Isaac Kaye]] is a founding member of the IHCV which was created in 2001 (through [[Isaac Kaye Family Trust]]). [[Harvey Kruger]], [[Steven Kaye]] and [[Warren Roiter]] are also reported to be founding members<ref><i>Company News Feed</i> formerly <i>Regulatory News Service</i> 'XTL Biopharm Ltd - XTLbio Announces Purchase of 14% Stake by IHCV'. 17th July 2003</ref>. |
| − | In 2003, it is reported that IHCV purchased a 14% stake in [[XTL Biopharmaceuticals Ltd]] (XTLbio)<ref><i>Company News Feed</i> formerly <i>Regulatory News Service</i> 'XTL Biopharm Ltd - XTLbio Announces Purchase of 14% Stake by IHCV'. 17th July 2003</ref> | + | The IHCV describes itself as 'a venture capital fund dedicated to providing venture capital investment to Israeli life sciences companies'<ref>Israel Healthcare Ventures [http://www.ihcv.co.il/ Home Page] Accessed 9th April 2008</ref>. It's headquarters is in Tel Aviv, Israel. |
| + | |||
| + | In 2003, it is reported that IHCV purchased a 14% stake in [[XTL Biopharmaceuticals Ltd]] (XTLbio), a biopharmaceutical company formed in 1993 which develops drugs to treat hepatitis<ref><i>Company News Feed</i> formerly <i>Regulatory News Service</i> 'XTL Biopharm Ltd - XTLbio Announces Purchase of 14% Stake by IHCV'. 17th July 2003</ref> | ||
| + | |||
| + | ==People== | ||
| + | * [[Hadar Ron]] - Managing Director<ref><i>Company News Feed</i> formerly <i>Regulatory News Service</i> 'XTL Biopharm Ltd - XTLbio Announces Purchase of 14% Stake by IHCV'. 17th July 2003</ref> | ||
==References== | ==References== | ||
<references/> | <references/> | ||
Latest revision as of 12:51, 4 June 2008
Israel Healthcare Ventures (IHCV)[1] - Isaac Kaye is a founding member of the IHCV which was created in 2001 (through Isaac Kaye Family Trust). Harvey Kruger, Steven Kaye and Warren Roiter are also reported to be founding members[2].
The IHCV describes itself as 'a venture capital fund dedicated to providing venture capital investment to Israeli life sciences companies'[3]. It's headquarters is in Tel Aviv, Israel.
In 2003, it is reported that IHCV purchased a 14% stake in XTL Biopharmaceuticals Ltd (XTLbio), a biopharmaceutical company formed in 1993 which develops drugs to treat hepatitis[4]
People
References
- ↑ Hebrew University of Jerusalem Isaac Kaye Accessed 9th April 2008
- ↑ Company News Feed formerly Regulatory News Service 'XTL Biopharm Ltd - XTLbio Announces Purchase of 14% Stake by IHCV'. 17th July 2003
- ↑ Israel Healthcare Ventures Home Page Accessed 9th April 2008
- ↑ Company News Feed formerly Regulatory News Service 'XTL Biopharm Ltd - XTLbio Announces Purchase of 14% Stake by IHCV'. 17th July 2003
- ↑ Company News Feed formerly Regulatory News Service 'XTL Biopharm Ltd - XTLbio Announces Purchase of 14% Stake by IHCV'. 17th July 2003
